<DOC>
	<DOCNO>NCT02747355</DOCNO>
	<brief_summary>In adrenal tumor , investigator examine correlation WIESS criterion , prognosis tumor , different label index follow proliferation biomarkers : MCM3 , MCM2 , KI-67 , P53 , NEUROPILIN -1 , METALLOTHIONEIN , SEMAPHORIN-3A .</brief_summary>
	<brief_title>Expression Different Proliferation Biomarkers Adreno-cortical Tumors</brief_title>
	<detailed_description>One problem manage adrenocortical tumor ability distinguish benign malignant tumor , needle biopsy unable distinguish two situation . Therefore , image test demonstrate suspect malignant adrenal tumor , surgical excision tumor need . Usually , histological WIESS criterion use order determine malignancy . However , case adrenal tumor define WIESS criterion benign metastasize later . Moreover , reliable test determine prognosis . KI-67 label index proliferation biomarker use tell malignant potential prognosis adrenal carcinoma . In various type tumor , proliferation biomarkers use attempt tell prognosis . In study , investigator examine whether biomarkers differentiate adrenal carcinoma adenoma degree expression marker correlate prognosis . The investigator retrospectively collect 30 case adrenal carcinoma , 30 case adrenal adenoma 10 case normal adrenal . All specimens preserve formalin . The investigator re-review WIESS criterion sample analyze index label follow proliferation biomarkers : MCM3 , MCM2 , KI-67 , P53 , NEUROPILIN -1 , METALLOTHIONEIN , SEMAPHORIN-3A . The investigator examine correlation label index biomarker , WIESS criterion prognosis tumor .</detailed_description>
	<mesh_term>Adrenal Cortex Neoplasms</mesh_term>
	<mesh_term>Adrenal Cortex Diseases</mesh_term>
	<criteria>adrenal carcinoma adrenal adenoma normal adrenal tissue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>